全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Hemoglobin Variant (Hemoglobin Aalborg) Mimicking Interstitial Pulmonary Disease

DOI: 10.1155/2014/701839

Full-Text   Cite this paper   Add to My Lib

Abstract:

Hemoglobin Aalborg is a moderately unstable hemoglobin variant with no affiliation to serious hematological abnormality or major clinical symptoms under normal circumstances. Our index person was a healthy woman of 58, not previously diagnosed with hemoglobinopathy Aalborg, who developed acute respiratory failure after a routine cholecystectomy. Initially she was suspected of idiopathic interstitial lung disease, yet a series of tests uncovered various abnormal physiological parameters and set the diagnosis of hemoglobinopathy Aalborg. This led us to examine a group of the index person’s relatives known with hemoglobinopathy Aalborg in order to study whether the same physiological abnormalities would be reencountered. They were all subjected to spirometry and body plethysmography, six-minute walking test, pulse oximetry, and arterial blood gas samples before and after the walking test. The entire study population presented the same physiological anomalies: reduction in diffusion capacity, and abnormalities in and p50 values; the latter could not be presented by the arterial blood gas analyzer; furthermore there was concordance between pulse oximetry and arterial blood gas samples regarding saturation. These data suggest that, based upon the above mentioned anomalies in physiological parameters, the diagnosis of hemoglobinopathy Aalborg should be considered. 1. Introduction Unstable hemoglobinopathies (Hb) are a rare disease entity of mutational events in the hemoglobin which are characterized by substitutions in the primary sequence of the globin [1]. These mutations alter the tertiary or quaternary structure of the molecule and therefore cause destabilization of the hemoglobin tetramer. A wide range of hemoglobin instabilities are known from in vitro studies, and the clinical findings span from subclinical cases to cases with severe hemolytic disease, for example, beta-thalassemia major or sickle cell disease [2]. Hb present with a broad spectrum of clinical manifestations; however, patients often have very few symptoms apart from slight fatigue, because the hemoglobin is often stable under clinically stable conditions [1–4]. Hemoglobin Aalborg is a rare, unstable hemoglobin variant where a glycine residue (E18) is replaced by arginine (β74(E18)Gly->Arg). The incidence and prevalence of Hb Aalborg are not known. It has a reduced oxygen affinity, both in the absence and in the presence of organic phosphates, and a raised oxygen affinity for organic phosphates, despite the fact that the replaced amino acid residue is too far from the heme to affect it

References

[1]  M. A. Lichtman, T. J. Kipps, U. Seligsohn, and K. P. J. Kaushansky, Williams Hematology, McGraw-Hill, New York, NY, USA, 8th edition, 2010.
[2]  D. Williamson, J. Nutkins, S. Rosthoj, S. O. Brennan, D. H. Williams, and R. W. Carrell, “Characterization of Hb Aalborg, a new unstable hemoglobin variant, by fast atom bombardment mass spectrometry,” Hemoglobin, vol. 14, no. 2, pp. 137–145, 1990.
[3]  H. Lehmann and R. W. Carrell, “Variations in the structure of human haemoglobin: with particular reference to the unstable haemoglobins,” British Medical Bulletin, vol. 25, no. 1, pp. 14–23, 1969.
[4]  E. R. Huehns, “Diseases due to abnormalities of hemoglobin structure,” Annual Review of Medicine, vol. 21, pp. 157–178, 1970.
[5]  G. Fermi, M. F. Perutz, D. Williamson, and D. T. Shih, “Structure-function relationships in the low-affinity mutant haemoglobin Aalborg (Gly74 (E18)beta—Arg),” Journal of Molecular Biology, vol. 226, pp. 883–888, 1992.
[6]  C.-P. Criée, “Whole-body plethysmography,” Medizinische Klinik, vol. 105, no. 9, pp. 652–660, 2010.
[7]  P. L. Enright, “The six-minute walk test,” Respiratory Care, vol. 48, no. 8, pp. 783–785, 2003.
[8]  N. MacIntyre, R. O. Crapo, G. Viegi et al., “Standardisation of the single-breath determination of carbon monoxide uptake in the lung,” Revue des Maladies Respiratoires, vol. 24, no. 3, pp. S65–S82, 2007.
[9]  A. J. Williams, “ABC of oxygen: assessing and interpreting arterial blood gases and acid-base balance,” The British Medical Journal, vol. 317, no. 7167, pp. 1213–1216, 1998.
[10]  M. Siggaard-Andersen and O. Siggaard-Andersen, “Oxygen status algorithm, version 3, with some applications,” Acta Anaesthesiologica Scandinavica, Supplement, vol. 39, no. 107, pp. 13–20, 1995.
[11]  “World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects,” Journal of the American Medical Association, vol. 310, pp. 2191–2194, 2013.
[12]  P. L. Enright and J. K. Stoller, “Diffusion capacity for carbon monoxide,” http://www.uptodate.com/contents/diffusing-capacity-for-carbon-monoxide#H14.
[13]  R. C. Young Jr., R. E. Rachal, C. A. Reindorf et al., “Lung function in sickle cell hemoglobinopathy patients compared with healthy subjects,” Journal of the National Medical Association, vol. 80, no. 5, pp. 509–514, 1988.
[14]  G. Piatti, L. Allegra, V. Fasano, C. Gambardella, M. Bisaccia, and M. D. Cappellini, “Lung function in -thalassemia patients: a longitudinal study,” Acta Haematologica, vol. 116, no. 1, pp. 25–29, 2006.
[15]  U. Froelund, E. Sandbakken, P. Szecsi, and H. Birgens, “Further studies on Hb canebière [β12(G4)AsnHis], a low affinity hemoglobin variant,” Hemoglobin, vol. 34, no. 5, pp. 495–499, 2010.
[16]  Y. Wu, G. V. Ramani, Q. Gai, L. C. Lemon, and M. R. Baer, “Rare hemoglobinopathy presenting as progressive dyspnea,” American Journal of Hematology, vol. 85, no. 5, pp. 355–357, 2010.
[17]  E. S. Klings, D. F. Wyszynski, V. G. Nolan, and M. H. Steinberg, “Abnormal pulmonary function in adults with sickle cell anemia,” American Journal of Respiratory and Critical Care Medicine, vol. 173, no. 11, pp. 1264–1269, 2006.
[18]  G. Piatti, L. Allegra, U. Ambrosetti, M. D. Cappellini, F. Turati, and G. Fiorelli, “β-Thalassemia and pulmonary function,” Haematologica, vol. 84, no. 9, pp. 804–808, 1999.
[19]  J. R. Kambam, L. H. Chen, and S. A. Hyman, “Effect of short-term smoking halt on carboxyhemoglobin levels and P50 values,” Anesthesia and Analgesia, vol. 65, no. 11, pp. 1186–1188, 1986.
[20]  G. Stamatoyannopoulos, A. J. Bellingham, C. Lenfant, and C. A. Finch, “Abnormal hemoglobins with high and low oxygen affinity,” Annual Review of Medicine, vol. 22, pp. 221–234, 1971.
[21]  M. Verhovsek, M. P. A. Henderson, G. Cox, H. Luo, M. H. Steinberg, and D. H. K. Chui, “Erratum to: unexpectedly low pulse oximetry measurements associated with variant hemoglobins: a systematic review,” American Journal of Hematology, vol. 86, no. 8, pp. 722–725, 2011.
[22]  C. M. Bruns, L. A. Thet, R. D. Woodson, J. Schultz, and K. M. Hla, “Hemoglobinopathy case finding by pulse oximetry,” American Journal of Hematology, vol. 74, no. 2, pp. 142–143, 2003.
[23]  J. Abdulla, L. C. Laursen, and C. B. Thomsen, “Arterial puncture or pulse oximetry?” Ugeskrift for L?ger, vol. 161, no. 8, pp. 1110–1112, 1999.
[24]  B. J. Wilson, H. J. Cowan, J. A. Lord, D. J. Zuege, and D. A. Zygun, “The accuracy of pulse oximetry in emergency department patients with severe sepsis and septic shock: a retrospective cohort study,” BMC Emergency Medicine, vol. 10, article 9, 2010.

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133